Targeted immunomodulation with H2-generating nanostructures to mitigate obesity-induced inflammation and metabolic dysfunctions
{{output}}
Obesity-induced inflammation in visceral adipose tissue (VAT) is a major driver of metabolic dysfunctions, contributing to severe health conditions such as insulin resistance, diabetes, and fatty liver disease. Current anti-inflammatory therapies lack specific... ...
